Anchorage Capital Group, L.L.C. 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Anchorage Capital Group, L.L.C. disclosed 4 US equity positions worth $117.4m in its Q3 2025 13F filing. The largest position was S at 74.1% of the reported book, followed by DNA and AMBP. Against the Q2 2025 filing, it opened 0 new positions, added to 0 and reduced 0 among the top 4 holdings.
What did Anchorage Capital Group, L.L.C. own in Q3 2025? Top 4 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | S SENTINELONE INC | Technology | 74.1% | $86.9m | 4,937,053 | 0% | held |
| 2 | DNA GINKGO BIOWORKS HOLDINGS INC | 21.7% | $25.5m | 1,746,363 | 0% | held | |
| 3 | AMBP ARDAGH METAL PACKAGING S A | Consumer Cyclical | 4.2% | $5.0m | 1,250,000 | 0% | held |
| 4 | ARDAGH METAL PACKAGING S A | 0.0% | $15.7k | 1,245,385 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.